Publications

Export 64 results:
Sort by: Author Title Type [ Year (Desc)]
2020
G, E., E. T, E. y A, A. M, and E. K. M, "Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt", Expert Review of Anti Infective Therapy, vol. 2020, pp. 1-6, 2020.
application/pdf icon53.pdf
AO, A., N. MM, O. DA, E. TM, and et al, "Hepatocellular Carcinoma Multidisciplinary Clinic-Cairo University (HMC-CU) score: A new simple score for diagnosis of HCC", Arab Journal of Gastroenterology, vol. 1979, issue 20, pp. 30012-30015, 2020.
application/pdf icon51.pdf
S, H., E. H. M, H. S, E. TM, and et al, "Machine Learning Prediction Models for Diagnosing Hepatocellular Carcinoma with HCV-related Chronic Liver Disease", Computer Methods and Programs in Biomedicine, vol. 196, pp. 105551, 2020.
application/pdf icon54.pdf
HI, S., F. R, E. TM, S. D, and et al, "Predictors of recurrence and survival of hepatocellular carcinoma: A prospective study including transient elastography and cancer stem cell markers", Arab Journal of Gastroenterology, vol. 1979, issue 20, pp. 30011-30013, 2020.
application/pdf icon52.pdf
2019
Elbaz, T., M. Abdo, H. Omar, and G. Esmat, "Efficacy and safety of sofosbuvir and daclatasvir with or without ribavirin in elderly patients with chronic hepatitis C virus infection", Journal of Medical Virology, vol. 91, issue 2, pp. 272-277, 2019.
application/pdf icon44.pdf
Zayed, S. A., N. M. Zahran, T. M. Elbaz, and A. R. Korany, "Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma", Journal of Medical Virology, vol. 91, issue 8, pp. 1537-1544, 2019.
application/pdf icon47.pdf
Saleh, A. M., E. A. Hassan, T. M. Elbaz, and S. Abd-Elsalam, "Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt", Infection and Drug Resistance, vol. 12, pp. 2277-2282, 2019.
application/pdf icon49.pdf
Abdelaziz, A. O., H. Abdelhalim, A. Elsharkawy, T. Elbaz, and M. M. Nabeel, "Liver stiffness measurement changes following hepatocellular carcinoma treatment with percutaneous microwave ablation or transarterial chemoembolization: a cohort study", European Journal of Gastroenterology and Hepatology, vol. 31, issue 6, pp. 685-691, 2019.
application/pdf icon46.pdf
Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, and T. M. Elbaz, "Tumor behavior of hepatocellular carcinoma after hepatitis C treatment by direct-acting antivirals: comparative analysis with non-direct-acting antivirals-treated patients", European Journal of Gastroenterology and Hepatology, vol. 31, issue 1, pp. 75-79, 2019.
application/pdf icon45.pdf
El Kassas, M., T. Elbaz, A. Kaseb, and G. Esmat, "[48] Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues - A mini-review", Journal of Advanced Research, vol. 17, pp. 43-48, 2019.
application/pdf icon48.pdf
2018
Omar, H., W. elakel, T. Elbaz, and W. D. Gamal Esmat, Mohamed Said, "Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in Egypt.", Alimentary Pharmacology and Therapeutics, vol. 47, issue 3, pp. 421-431, 2018. sof_dac_paper.pdf
Esmat, G., N. Zayed, and T. Elbaz, "Parasitic Liver Disease", Zakim and Boyer's Hepatology 7th Edition A Textbook of Liver Disease, Philadelphia, Elsevier, 2018. chapter_39_zakim_and_boyer.pdf
Attia, D., W. elakel, T. Elbaz, M. El Raziky, and G. Esmat, "The adverse effects of interferon-free regimens in 149 816 chronic hepatitis C treated Egyptian patients", Alimentary Pharmacology and Therapeutics, vol. 47, issue 9, pp. 1296-1305, 2018.
application/pdf icon41.pdf
Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, and T. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus", European Journal of Gastroenterology and Hepatology, vol. 30, issue 1, pp. 39-43, 2018.
application/pdf icon36.pdf
fayed, A. A. E. K. A. E. S., H. A. Sami, A. H. Kamel, T. M. Elbaz, and B. E. M. H. Mahmoud, "Discrimination between malignant and bland portal vein thrombosis: Could T diffusion weighted MRI help", The Egyptian Journal of Radiology and Nuclear Medicine, vol. 49, issue 2018, pp. 608-613, 2018.
application/pdf iconb9.pdf
Fouad, R., T. Elbaz, S. A. Alem, and G. Esmat, "Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients", European Journal of Gastroenterology and Hepatology, vol. 30, issue 8, pp. 882-887, 2018.
application/pdf icon42.pdf
Abdelaziz, A. O., H. I. Shousha, T. Elbaz, and F. M. Abdelsalam, "Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma", European Journal of Gastroenterology and Hepatology, vol. 30, issue 11, pp. 1384-1388, 2018.
application/pdf icon43.pdf
Alsawy, N. F., R. K. Darwish, H. I. Shousha, and T. M. Elbaz, "Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma", Journal of Medical Virology, vol. 90, issue 3, pp. 490-496, 2018.
application/pdf icon33.pdf
El Kassas, M., T. Elbaz, A. Elsharkawy, and G. Esmat, "HCV in Egypt, prevention, treatment and key barriers to elimination", Expert Review of Anti Infective Therapy, vol. 16, issue 4, pp. 345-350, 2018.
application/pdf icon39.pdf
Alem, S. A., M. Said, T. Elbaz, and A. Yosry, "Improvement of LSM, ARFI measurements and non-invasive fibrosis markers after DAAs for HCV G4 recurrence post living donor liver transplantation: Egyptian cohort", Journal of Medical Virology, vol. 90, issue 9, pp. 1508-1515, 2018.
application/pdf icon40.pdf
Abdelaziz, A. O., H. I. Shousha, T. Elbaz, and M. M. Nabil, "A new prognostic score can predict survival after hepatocellular carcinoma treatment in a cohort of 1302 Egyptian hepatocellular carcinoma patients", European Journal of Gastroenterology and Hepatology, vol. 30, issue 5, pp. 514-519, 2018.
application/pdf icon38.pdf
Gamil, M., M. Alboraie, M. El-Sayed, T. Elbaz, and G. Esmat, "Novel scores combining AFP with non-invasive markers for prediction of liver fibrosis in chronic hepatitis C patients", Journal of Medical Virology, vol. 90, issue 6, pp. 1080-1086, 2018.
application/pdf icon37.pdf
Waked, I., H. Omar, T. Elbaz, and G. Esmat, "Ravidasvir hydrochloride", Drugs of the Future, vol. 43, pp. 97-108, 2018.
application/pdf icon50.pdf
2017
Elbaz, T., M. E. Serafy, W. elakel, and G. Esmat, "Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian Experience", Journal of Interferon and Cytokine Research, vol. 37, issue 8, pp. 348-353, 2017. serious_aes_jicr.pdf
Abdelaziz, A. O., A. H. Abdelmaksoud, M. M. Nabeel, and T. M. Elbaz, "Transarterial Chemoembolization Combined with Either Radiofrequency or Microwave Ablation in Management of Hepatocellular Carcinoma ", Asian Pacific Journal of Cancer Prevention, vol. 18, issue 1, pp. 189-194, 2017. combined_ablation.pdf